Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Asia Congress 2023

GSK - Evolving role of immune checkpoint inhibitors (ICIs) in solid tumors: Expert perspectives

Perspective on single-agent PD-1 blockade in dMMR CRC/solid tumors

Date

01 Dec 2023

Session

GSK - Evolving role of immune checkpoint inhibitors (ICIs) in solid tumors: Expert perspectives

Presenters

Takayuki Yoshino

Authors

T. Yoshino

Author affiliations

  • Department Of Gastroenterology And Gastrointestinal Oncology, National Cancer Center Hospital East, 277-8577 - Kashiwa/JP

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

General Q&A and closing

Presenter: All Speakers

Session: GSK - Evolving role of immune checkpoint inhibitors (ICIs) in solid tumors: Expert perspectives

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.